Home
Journal Issues
Current Issue
All Issues
In Progress
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
3080-0382
Biomed adv
. 2025;2(3): 137-145. doi:
10.34172/bma.28
Original Article
Carvacrol and paclitaxel: Synergistic effect on apoptosis in breast cancer cell lines
Hassan Dariushnejad
1
, Sara Garavand
2
, Hamed Esmaeil Lashgarian
1
,
2
, Changiz Ahmadizadeh
3
, Tooba Ahmadi
2
, Ayat Moradipour
4
*
Cited by CrossRef: 0
1- Abuaisha A, Nekay E, Yilmaz O, Yildiz B, Mecit T, Yavas C, Papila B, Arslan H, Gumus A, Nazligul E, Akbas S, Emiroglu S. Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation.
Biology
. 2025;14(10):1443
[Crossref]
2- Ahmadi T, Ghorbanzadeh V, Hosseinnejad E, Zynivand M, Moradipour A, Dariushnejad H. Exosomal MALAT1 expression associated with the cardioprotective effects of carvacrol in acute doxorubicin-induced cardiac injury: Potential involvement of Nrf2/Keap1-related signaling.
Biomedicine & Pharmacotherapy
. 2026;200:119606
[Crossref]
Submit Your Paper
Editorial Board
Editorial Policies
Aims and Scope
For Authors
Archive
Acceptance Rate:
35%
Submission to First Decision:
20 Days
Received to Acceptance:
60 Days
Acceptance to Publication:
40 Days
*
Average article statistics from the last 12 months of data.
In
collaboration with